Cookie Settings
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Other cookies are those that are being identified and have not been classified into any category as yet.

No cookies to display.

mRNA Technology Transfer Programme

mRNA technology transfer programme

The mRNA technology transfer programme is a global initiative that aims to improve health and health security by establishing sustainable, locally owned mRNA manufacturing capabilities in and for low- and middle-income countries (LMICs).The programme is based around a technology transfer “hub”  Afrigen, which is located in South Africa. They will provide the technology development, training and technology transfer, and currently 15 programme partners in LMICs across the world are receiving training and technology from the hub and will then produce and sell products commercially. Its core concept is empowerment.

Initially the programme is focusing on mRNA vaccines against COVID-19. However, the programme is designed to encourage the development of other mRNA vaccines and therapeutics against important diseases that threaten LMICs, thereby ensuring the capacity built by the project is sustained and available to combat the next pandemic.

 

mRNA Technology Transfer

 

mRNA Technology latest news

Share page: